This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Kei Segawa: Innovator in Quaternary Ammonium Salt Compounds
Introduction
Kei Segawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quaternary ammonium salt compounds. His research focuses on developing compounds with specific receptor activities that can lead to advancements in medical treatments.
Latest Patents
Kei Segawa holds a patent for quaternary ammonium salt compounds. The primary objective of this invention is to provide a novel compound that exhibits β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. The invention is represented by a specific formula and includes pharmaceutically acceptable salts that demonstrate superior activity in these areas.
Career Highlights
Segawa is currently employed at Teijin Pharma Limited, where he continues to engage in innovative research and development. His work has contributed to the advancement of pharmaceutical compounds that can potentially improve therapeutic outcomes for patients.
Collaborations
Some of his notable coworkers include Etsuko Mitsuyama and Satoshi Yamamura. Their collaborative efforts in research have further enhanced the development of new pharmaceutical solutions.
Conclusion
Kei Segawa's contributions to the field of pharmaceutical chemistry, particularly through his patent on quaternary ammonium salt compounds, highlight his role as an innovator. His work continues to pave the way for advancements in medical treatments.